Purple Biotech's market cap is currently ―. The company's EPS TTM is $-0.91; its P/E ratio is -0.74; Purple Biotech is scheduled to report earnings on May 9, 2024, and the estimated EPS forecast is $-0.19. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Sep 22	Jun 22	Mar 22
Income Statement	-
Total Revenue	-	-	$ 0.00	$ 0.00	$ 0.00
Gross Profit	-	-	-	-	-
EBIT	-	-	$ -4.83M	$ -3.50M	$ -7.28M
EBITDA	-	-	$ -4.79M	$ -3.45M	$ -7.22M
Net Income Common Stockholders	-	-	$ -4.82M	$ -3.54M	$ -7.30M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 15.41M	$ 31.68M	$ 33.08M	$ 36.02M	$ 39.55M
Total Assets	$ 44.30M	$ 54.62M	$ 58.54M	$ 61.74M	$ 66.29M
Total Debt	$ 351.00K	$ 515.00K	$ 550.00K	$ 594.00K	$ 694.00K
Net Debt	$ -15.06M	$ -31.17M	$ -32.53M	$ -35.42M	$ -38.85M
Total Liabilities	$ 10.01M	$ 7.52M	$ 6.43M	$ 6.08M	$ 7.97M
Stockholders Equity	$ 34.21M	$ 46.91M	$ 51.89M	$ 55.41M	$ 58.06M
Cash Flow	-
Free Cash Flow	-	-	$ -3.63M	$ -3.71M	$ -5.42M
Operating Cash Flow	-	-	$ -3.62M	$ -3.70M	$ -5.20M
Investing Cash Flow	-	-	$ 177.00K	$ -5.98M	$ 17.72M
Financing Cash Flow	-	-	$ 569.00K	$ 294.00K	$ 162.00K

Currency in USD

Purple Biotech Earnings and Revenue History

Income Statement >

Purple Biotech Debt to Assets

Balance Sheet >

Purple Biotech Cash Flow

Cash Flow >

Purple Biotech Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing